[Clinical pharmacology of adrenergic agonists and antagonists. I. Alpha-adrenergic agonists and antagonists].
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000704:Analysis of Variance; D003692:Delayed-Action Preparations; D004877:Ergoloid Mesylates / Q000494:pharmacology; D006801:Humans; D008722:Methods; D013948:Moxisylyte / Q000494:pharmacology; D009184:Mydriatics / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010656:Phenylephrine / Q000494:pharmacology; D011680:Pupil / Q000187:drug effects*
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D003692:Delayed-Action Preparations; D009184:Mydriatics; D010656:Phenylephrine; D004877:Ergoloid Mesylates; D013948:Moxisylyte
Pharmacologie clinique des agonistes et des antagonistes adrénergiques. I. Agonistes et antagonistes alpha-adrénergiques.